BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27538392)

  • 1. Original article: role of adjuvant chemotherapy in a perioperative chemotherapy regimen for gastric cancer.
    Lichthardt S; Kerscher A; Dietz UA; Jurowich C; Kunzmann V; von Rahden BH; Germer CT; Wiegering A
    BMC Cancer; 2016 Aug; 16():650. PubMed ID: 27538392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the Survival Impact of Postoperative Chemotherapy After Preoperative Chemotherapy and Resection for Gastric Cancer.
    Drake JA; Stiles ZE; Tsao MW; Deneve JL; Glazer ES; Yakoub D; Grothey A; Somer BG; Dickson PV
    Ann Surg Oncol; 2021 Mar; 28(3):1417-1427. PubMed ID: 32856227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.
    Tsuburaya A; Mizusawa J; Tanaka Y; Fukushima N; Nashimoto A; Sasako M;
    Br J Surg; 2014 May; 101(6):653-60. PubMed ID: 24668391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative chemotherapy for resectable gastroesophageal cancer: a single-center experience.
    Molina R; Lamarca A; Martínez-Amores B; Gutiérrez A; Blázquez A; López A; Granell J; Álvarez-Mon M
    Eur J Surg Oncol; 2013 Aug; 39(8):814-22. PubMed ID: 23755989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative adjuvant treatment for gastric cancer improves long-term survival after curative resection and D2 lymphadenectomy. Results from a Latin American Center.
    Norero E; Bustos M; Herrera ME; Cerda J; González P; Ceroni M; Martínez C; Briceño E; Rojas H; Cártes R; Lopez V; Hidalgo V; Báez S; Caracci M; Viñuela E; Díaz A
    Eur J Surg Oncol; 2016 Jan; 42(1):94-102. PubMed ID: 26577767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study.
    Persiani R; Rausei S; Pozzo C; Biondi A; Barone C; Cananzi FC; Schinzari G; D'Ugo D
    Ann Surg Oncol; 2008 Aug; 15(8):2146-52. PubMed ID: 18543037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor regression and survival after perioperative MAGIC-style chemotherapy in carcinoma of the stomach and gastroesophageal junction.
    Mingol F; Gallego J; Orduña A; Martinez-Blasco A; Sola-Vera J; Moya P; Morcillo MA; Ruiz JA; Calpena R; Lacueva FJ
    BMC Surg; 2015 May; 15():66. PubMed ID: 25997454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer.
    Yoshikawa T; Sasako M; Yamamoto S; Sano T; Imamura H; Fujitani K; Oshita H; Ito S; Kawashima Y; Fukushima N
    Br J Surg; 2009 Sep; 96(9):1015-22. PubMed ID: 19644974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma.
    Leong CN; Chung HT; Lee KM; Shakespeare TP; Mukherjee RK; Wong LC; Lu JJ; Tey J; Lim R; So JB; Back MF
    Cancer J; 2008; 14(4):269-75. PubMed ID: 18677137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric cancer: surgery in 2011.
    Ott K; Lordick F; Blank S; Büchler M
    Langenbecks Arch Surg; 2011 Aug; 396(6):743-58. PubMed ID: 21234760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative platin-based chemotherapy for locally advanced esophagogastric adenocarcinoma: Postoperative chemotherapy has a substantial impact on outcome.
    Glatz T; Bronsert P; Schäfer M; Kulemann B; Marjanovic G; Sick O; Hopt UT; Zirlik K; Makowiec F; Hoeppner J
    Eur J Surg Oncol; 2015 Oct; 41(10):1300-7. PubMed ID: 26253194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraarterial chemotherapy as an adjuvant treatment in locally advanced gastric cancer.
    Tentes AA; Markakidis SK; Karanikiotis C; Fiska A; Tentes IK; Manolopoulos VG; Dimitriou T
    Langenbecks Arch Surg; 2006 Apr; 391(2):124-9. PubMed ID: 16534653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer.
    Barone C; Cassano A; Pozzo C; D'Ugo D; Schinzari G; Persiani R; Basso M; Brunetti IM; Longo R; Picciocchi A
    Oncology; 2004; 67(1):48-53. PubMed ID: 15459495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of somatostatin in advanced gastric cancer after D2 radical gastrectomy.
    Song W; Chen JH; Zhang XH; Xu JB; He YL; Cai SR; Han FH; Chen CQ
    World J Gastroenterol; 2014 Oct; 20(40):14927-33. PubMed ID: 25356053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical Gastrectomy: Still the Cornerstone of Curative Treatment for Gastric Cancer in the Perioperative Chemotherapy Era-A Single Institute Experience over a Decade.
    Kanhere H; Goel R; Finlay B; Trochsler M; Maddern G
    Int J Surg Oncol; 2018; 2018():9371492. PubMed ID: 29568650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in the use and impact of neoadjuvant chemotherapy on perioperative outcomes for resected gastric cancer: Evidence from the American College of Surgeons National Cancer Database.
    Greenleaf EK; Hollenbeak CS; Wong J
    Surgery; 2016 Apr; 159(4):1099-112. PubMed ID: 26704785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer.
    Mrena J; Mattila A; Böhm J; Jantunen I; Kellokumpu I
    World J Gastroenterol; 2015 Dec; 21(47):13294-301. PubMed ID: 26715812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radical Gastrectomy After Chemotherapy May Prolong Survival in Stage IV Gastric Cancer: A Korean Multi-institutional Analysis.
    Seo HS; Song KY; Jung YJ; Park SM; Jeon HM; Kim W; Chin HM; Kim JJ; Kim SK; Chun KH; Kim JG; Lee JH; Lee HH; Kim DJ; Yoo HM; Kim CH; Kim EY; Park CH;
    World J Surg; 2018 Oct; 42(10):3286-3293. PubMed ID: 29717344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical therapy of non-Hodgkin lymphoma of the stomach].
    Zippel K; Agnes A; Zieren HU
    Zentralbl Chir; 1998; 123(1):53-7. PubMed ID: 9542031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Hyperthermic Intraperitoneal Perfusion Chemotherapy in Combination with Intravenous Chemotherapy as Postoperative Adjuvant Therapy for Advanced Gastric Cancer.
    Wu Z; Ma S; Jing S; Deng Q; Zheng Z; Wu K; Li J; Chen S; Tang R; Li X
    Hepatogastroenterology; 2014 Jun; 61(132):972-7. PubMed ID: 26158151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.